Synthesis and pharmacological evaluation of carboxamide derivatives as selective serotoninergic 5-HT4 receptor agonists (European Journal of Medicinal Chemistry (1999) 34 (329-987))

European Journal of Medicinal Chemistry

Volumn 34, Issue 11, 1999, Pages 977-989

  Itoh, Katsuhiko ^a   Kanzaki, Koji ^a   Ikebe, Tsuguo ^a   Kuroita, Takanobu ^a   Tomozane, Hideo ^a   Sonda, Shuji ^a   Sato, Noriko ^a   Haga, Keiichiro ^a   Kawakita, Takeshi ^a  

^a Yoshitomi Pharmaceutical Industries Ltd   (Japan)

Author keywords

5 HT4 receptor; 5 HT4 receptor agonist; Carboxamide; Receptor model construction; Structure activity relationship

Indexed keywords

4 AMINO 5 CHLORO 2 METHOXY N [1 [2 [(METHYLSULFONYL)AMINO]ETHYL] 4 PIPERIDINYLMETHYL]BENZAMIDE; BENZOXAZINE 8 CARBOXAMIDE DERIVATIVE; BENZOXAZINE DERIVATIVE; CLEBOPRIDE; DOPAMINE 2 RECEPTOR; GRANISETRON; SEROTONIN 3 RECEPTOR; SEROTONIN 4 AGONIST; SPIPERONE; TRITIUM; UNCLASSIFIED DRUG;

ANIMAL TISSUE; BINDING AFFINITY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; ERRATUM; INTESTINE CONTRACTION; LIGAND BINDING; NONHUMAN; SEROTONINERGIC SYSTEM; STRUCTURE ACTIVITY RELATION;

EID: 0032745382     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0223-5234(99)00158-0     Document Type: Erratum

References (38)

1. Alexander S.H., Peters J.A. TPiS Receptor and Ion Chanenel Nomenclature Supplement, Elsevier. 1998;46-48.
2. Eglen R.M., Wong E.F., Dumuis A., Bockaert J. Trends Pharmacol. Sci. 16:1995;391-398.
3. Craig D.A., Clarke D.E. J. Pharmacol. Exp. Ther. 252:1990;1378-1386.
4. Elswood C.J., Bunce K.T., Humphrey P.P.A. Eur. J. Pharmacol. 196:1991;149-155.
5. Briejer M.R., Akkerman L.S., Meulemans A.L., Lefebvre R.A., Schuurkes L.J. Naunyn-Schmiederg's Arch. Pharmacol. 347:1993;464-470.
6. Rizzi C.A., Coccini T., Onori L., Manzo L., Tonini M. J. Pharmacol. Exp. Ther. 261:1992;412-419.
7. Langlois M., Zhang L., Yang D., Brémont B., Shen S., Manara L., Croci T. Bioorg. Med. Chem. Lett. 4:1994;1433-1436.
8. Dumuis A., Bouhelal R., Sebben M., Cory R., Bockaert J. Mol. Pharmacol. 34:1988;880-887.
9. Flynn D.L., Zabroski D.L., Becker D.P., Nosal R., Villamil C.L., Gullikson G.W., Moummi C., Yang D. J. Med. Chem. 35:1992;1487-1491.
10. Turconi M., Schiantarelli P., Borsini F., Rizzi C.A., Ladinsky H., Donetti A. Drugs Future. 16:1991;1011-1026.
11. Clark R.D., Jahangir A., Langston J.A., Weinhardt K.K., Miller A.B., Leung E., Eglen R.M. Bioorg. Med. Chem. Lett. 4:1994;2477-2480.
12. López-Rodríguez M.L., Morcillo M.J., Benhaú B., Rosado M.L. J. Comput.-Aided Mol. Des. 11:1997;589-599.
13. Kuroita T., Sakamori M., Kawakita T. Chem. Pharm. Bull. 44:1996;756-764.
14. Kuroita T., Ikebe T., Murakami S., Takehara S., Kawakita T. Bioorg. Med. Chem. Lett. 5:1995;1245-1250.
15. Tahara T., Hayano K., Murakami S., Fukuda T., Setoguti M., Ikeda K., Marubayasi N. Chem. Pharm. Bull. 38:1990;1609-1615.
16. Iwanami S., Takasima M., Hirata Y., Hasegawa O., Usuda S. J. Med. Chem. 24:1981;1224-1230.
17. Mitsunobu O. Synthesis. 1981;1-28.
18. Kawakita T., Kuroita T., Murozono T., Hakira H. WO 95/26953 Chem. Abstr. 124:1996;14913.
19. Fancelli D., Caccia C., Fornaretto M.G., McArthur R., Severino D., Vaghi F., Varasi M. Bioorg. Med. Chem. Lett. 6:1996;236-266.
20. Hibert M.F., Trumpp-Kallmeyer S., Bruinvels A., Hoflack J. Mol. Pharmacol. 40:1991;8-15.
21. Ijzerman A.P., Van Gallen P.M., Jacobson K.A. Drug Design Dev. 9:1992;49-67.
22. Trumpp-Kallmeyer S., Hoflack J., Bruinvels A., Hibert M. J. Med. Chem. 35:1992;3448-3462.
23. Yamamoto Y., Kamiya K., Terao S. J. Med. Chem. 36:1993;820-825.
24. Nordvall G., Hacksell U. J. Med. Chem. 36:1993;976.
25. Glennon R.A., Dukat M., Westkaemper R.B., Ismaiel A.M., Izzarelli D.G., Parker E.A. Mol. Pharmacol. 49:1996;198-206.
26. Teeter M.M., Froimowitz M.B., Durand C.J. J. Med. Chem. 37:1996;2874-2888.
27. Kotoyianni M., Deweese C., Penzotti J.E., Lybrand T.P. J. Med. Chem. 39:1996;4406-4420.
28. Kyte J., Doolittle R.F. J. Mol. Biol. 157:1982;105-132.
29. Begonia Y.H., Karschin A., Branchek T., Davidson N., Lester H.A. FEBS. Lett. 312:1992;259-262.
30. Johnson M.P., Loncharich R.J., Baez M., Nelson D.L. Mol. Pharmacol. 45:1993;277-286.
31. Almaula N., Ebersole B.J., Zhang D., Weinstein H., Sealfon S.C. J. Biol. Chem. 271:1996;14672-14675.
32. Almaula N., Ebersole B.J., Ballesteros J.A., Weinstein H., Sealfon S.C. Mol. Pharmacol. 50:1996;34-42.
33. Choudhary M.S., Craigo S., Roth B.L. Mol. Pharmacol. 43:1993;755-761.
34. Nelson D.R., Thomas D.R. Biochem. Pharmacol. 38:1989;1693-1695.
35. Bairoch A., Boeckmann B. Nucleic Acids Res. 20:1992;2019-2022.
36. Henderson R., Baldwin J.M., Ceska T.A., Zemlin F., Beckmann E.D. J. Mol. Biol. 213:1990;899-929.
37. Bernstein F.C., Koetzle T.F., Williams G.B., Meyer E.F. . Jr, Brice M.D., Rodgers J.R., Kennard O., Shimanouchi T., Tasumi M. J. Mol. Biol. 112:1977;535-542.
38. Tripos E & S, 6548 Clayton Road, St. Louis, MO 62117. SYBYL molecular modelling software.